Evidence map›Paper›PMID 38732285›Full record

ArticleDiagnostics (Basel, Switzerland)2024

Comparison of Early Contrast Enhancement Models in Ultrafast Dynamic Contrast-Enhanced Magnetic Resonance Imaging of Prostate Cancer.

Alfredo Clemente, Guerino Selva, Michael Berks, Federica Morrone, Aniello Alessandro Morrone, Michele De Cristofaro Aulisa, Ekaterina Bliakharskaia, Andrea De Nicola, Armando Tartaro, Paul E Summers

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Alfredo ClementeRadiology Unit, Centro Medicina Nucleare N1, "Centro Morrone", 81100 Caserta, Italy.ORCID 0000-0001-8783-8268
Guerino SelvaRadiology Unit, Centro Medicina Nucleare N1, "Centro Morrone", 81100 Caserta, Italy.
Michael BerksQuantitative Biomedical Imaging Laboratory, Division of Cancer Sciences, University of Manchester, Manchester M13 9PL, UK.
Federica MorroneRadiology Unit, Centro Radiologico Vega, "Centro Morrone", 81100 Caserta, Italy.
Aniello Alessandro MorroneRadiology Unit, Centro Radiologico Vega, "Centro Morrone", 81100 Caserta, Italy.
Michele De Cristofaro AulisaDepartment of Biotechnological and Applied Clinical Sciences, University of L'Aquila, 67100 L'Aquila, Italy.
Ekaterina BliakharskaiaDepartment of Neuroscience and Imaging, University G. d'Annunzio, 66100 Chieti, Italy.ORCID 0009-0007-5943-9586
Andrea De NicolaRadiology Unit, SS. Annunziata Hospital, ASL Lanciano Vasto Chieti, 66100 Chieti, Italy.ORCID 0000-0002-8837-9267
Armando TartaroDepartment of Clinical, Oral Sciences and Biotechnology, University "G. d'Annunzio", 66100 Chieti, Italy.
Paul E SummersQMRI Tech, 65123 Pescara, Italy.ORCID 0000-0002-5085-1095

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tofts models have failed to produce reliable quantitative markers for prostate cancer. We examined the differences between prostate zones and lesion PI-RADS categories and grade group (GG) using regions of interest drawn in tumor and normal-appearing tissue for a two-compartment uptake (2CU) model (including plasma volume (v

Indexed as

empirical mathematical modelpharmacokinetic modelprostate cancerultrafast dynamic contrast enhanced MRI

Identifiers

PMID38732285
PMCPMC11083228

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.